Ketevan Pachkoria

2.0k total citations · 1 hit paper
18 papers, 1.5k citations indexed

About

Ketevan Pachkoria is a scholar working on Pharmacology, Oncology and Ophthalmology. According to data from OpenAlex, Ketevan Pachkoria has authored 18 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 7 papers in Oncology and 3 papers in Ophthalmology. Recurrent topics in Ketevan Pachkoria's work include Drug-Induced Hepatotoxicity and Protection (10 papers), Drug Transport and Resistance Mechanisms (6 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Ketevan Pachkoria is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (10 papers), Drug Transport and Resistance Mechanisms (6 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Ketevan Pachkoria collaborates with scholars based in Spain, Georgia and United States. Ketevan Pachkoria's co-authors include Raúl J. Andrade, M. Isabel Lucena, José Antonio Durán, Gloria Isabel Carvajal Peláez, B. García‐Muñoz, M. Carmen Fernández‐Santaella, Rocío González‐Grande, Ángeles Pizarro, Y. Borraz and Miren García‐Cortés and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of Hepatology.

In The Last Decade

Ketevan Pachkoria

18 papers receiving 1.4k citations

Hit Papers

Drug-Induced Liver Injury: An Analysis of 461 Incidences ... 2005 2026 2012 2019 2005 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ketevan Pachkoria Spain 13 1.2k 413 411 294 184 18 1.5k
Miren García‐Cortés Spain 18 1.3k 1.1× 378 0.9× 465 1.1× 340 1.2× 204 1.1× 55 1.8k
B. García‐Muñoz Spain 6 958 0.8× 315 0.8× 328 0.8× 255 0.9× 138 0.8× 8 1.1k
Rocío González‐Grande Spain 11 850 0.7× 291 0.7× 408 1.0× 379 1.3× 116 0.6× 14 1.3k
J.M. Navarro Spain 14 693 0.6× 257 0.6× 451 1.1× 406 1.4× 92 0.5× 19 1.4k
Mercedes Robles‐Díaz Spain 20 1.2k 1.0× 409 1.0× 561 1.4× 416 1.4× 141 0.8× 63 1.8k
Ángeles Pizarro Spain 7 691 0.6× 240 0.6× 388 0.9× 190 0.6× 98 0.5× 11 1.1k
Camilla Stephens Spain 19 1.0k 0.9× 324 0.8× 382 0.9× 302 1.0× 128 0.7× 44 1.5k
Y. Borraz Spain 9 767 0.7× 257 0.6× 226 0.5× 180 0.6× 109 0.6× 12 925
M Biour France 18 496 0.4× 178 0.4× 261 0.6× 164 0.6× 85 0.5× 80 1.4k
PB Watkins United States 8 904 0.8× 341 0.8× 345 0.8× 296 1.0× 139 0.8× 10 1.2k

Countries citing papers authored by Ketevan Pachkoria

Since Specialization
Citations

This map shows the geographic impact of Ketevan Pachkoria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ketevan Pachkoria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ketevan Pachkoria more than expected).

Fields of papers citing papers by Ketevan Pachkoria

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ketevan Pachkoria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ketevan Pachkoria. The network helps show where Ketevan Pachkoria may publish in the future.

Co-authorship network of co-authors of Ketevan Pachkoria

This figure shows the co-authorship network connecting the top 25 collaborators of Ketevan Pachkoria. A scholar is included among the top collaborators of Ketevan Pachkoria based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ketevan Pachkoria. Ketevan Pachkoria is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Pachkoria, Ketevan, et al.. (2020). ENDOCANNABINOIDS RECEPTORS MEDIATED CENTRAL AND PERIPHERAL EFFECTS (REVIEW).. PubMed. 137–143. 11 indexed citations
2.
Pachkoria, Ketevan, et al.. (2017). [ACTION OF L-CARNITINE, CORVITIN AND THEIR COMBINATION ON FUNCTIONAL STATE OF LIVER IN EXPERIMENTAL MODEL OF REYE SYNDROME IN RATS].. PubMed. 105–111. 2 indexed citations
3.
Alió, Jorge L., et al.. (2013). Intraocular Optical Quality of Phakic Intraocular Lenses: Comparison of Angle-Supported, Iris-Fixated, and Posterior Chamber Lenses. American Journal of Ophthalmology. 156(4). 789–799. 20 indexed citations
4.
Alió, Jorge L., et al.. (2013). Laser-Assisted In Situ Keratomileusis in High Mixed Astigmatism With Optimized, Fast-Repetition and Cyclotorsion Control Excimer Laser. American Journal of Ophthalmology. 155(5). 829–836. 24 indexed citations
5.
Pachkoria, Ketevan, et al.. (2013). Anterior stromal puncture for the treatment of Brown–McLean syndrome. Archivos de la Sociedad Española de Oftalmología (English Edition). 88(5). 193–196. 1 indexed citations
6.
García‐Cortés, Miren, M. Isabel Lucena, Ketevan Pachkoria, et al.. (2008). Evaluation of Naranjo Adverse Drug Reactions Probability Scale in causality assessment of drug‐induced liver injury. Alimentary Pharmacology & Therapeutics. 27(9). 780–789. 123 indexed citations
7.
Pachkoria, Ketevan, M. Isabel Lucena, Francisco Ruiz‐Cabello, et al.. (2008). Analysis of IL-10, IL-4 and TNF-α polymorphisms in drug-induced liver injury (DILI) and its outcome. Journal of Hepatology. 49(1). 107–114. 59 indexed citations
8.
Pachkoria, Ketevan, et al.. (2008). The mechanisms of neurodegenerative processes and current pharmacotherapy of Alzheimer's disease.. PubMed. 44–8. 14 indexed citations
9.
Pachkoria, Ketevan, et al.. (2007). Genetic and Molecular Factors in Drug-Induced Liver Injury: A Review. Current Drug Safety. 2(2). 97–112. 19 indexed citations
10.
Pachkoria, Ketevan, et al.. (2007). Genetic polymorphisms of CYP2C9 and CYP2C19 are not related to drug‐induced idiosyncratic liver injury (DILI). British Journal of Pharmacology. 150(6). 808–815. 33 indexed citations
11.
Lucena, M. Isabel, Raúl J. Andrade, M. Carmen Fernández, et al.. (2006). Determinants of the clinical expression of amoxicillin‐clavulanate hepatotoxicity. Hepatology. 44(4). 850–856. 110 indexed citations
12.
Andrade, Raúl J., M. Isabel Lucena, Neil Kaplowitz, et al.. (2006). Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry. Hepatology. 44(6). 1581–1588. 215 indexed citations
13.
García‐Cortés, Miren, et al.. (2006). 686 Comparison of two clinical scales in the causality assessment of drug induced liver disease. Journal of Hepatology. 44. S253–S253. 1 indexed citations
14.
Lucena, M. Isabel, et al.. (2006). Prolonged cholestasis after raloxifene and fenofibrate interaction: A case report.. PubMed. 12(32). 5244–6. 16 indexed citations
15.
Andrade, Raúl J., M. Isabel Lucena, M. Carmen Fernández‐Santaella, et al.. (2005). Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year Period. Gastroenterology. 129(2). 512–521. 740 indexed citations breakdown →
16.
Andrade, Raúl J., M. Isabel Lucena, M. Carmen Fernández, et al.. (2005). Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year Period. Gastroenterology. 129(2). 512–521. 66 indexed citations
17.
Pachkoria, Ketevan, et al.. (2005). Hepatotoxicidad por metilfenidato en el tratamiento del trastorno por déficit de atención con hiperactividad. 3(4). 270–271. 1 indexed citations
18.
Pachkoria, Ketevan, et al.. (2005). Significance of Cox-2 expression in rectal cancers with or without preoperative radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 63(3). 739–744. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026